Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

SELL
$0.48 - $0.74 $23,717 - $36,564
-49,412 Reduced 66.68%
24,692 $17,000
Q2 2023

Aug 14, 2023

SELL
$0.49 - $0.79 $41,490 - $66,892
-84,674 Reduced 53.33%
74,104 $55,000
Q1 2023

May 15, 2023

BUY
$0.56 - $1.24 $88,915 - $196,884
158,778 New
158,778 $116,000
Q2 2021

Aug 16, 2021

SELL
$5.11 - $7.64 $321,991 - $481,411
-63,012 Closed
0 $0
Q1 2021

May 17, 2021

BUY
$5.03 - $10.5 $255,202 - $532,728
50,736 Added 413.29%
63,012 $451,000
Q4 2020

Feb 16, 2021

BUY
$3.48 - $6.58 $42,720 - $80,776
12,276 New
12,276 $66,000
Q3 2020

Nov 16, 2020

SELL
$2.78 - $26.5 $65,785 - $627,096
-23,664 Closed
0 $0
Q2 2020

Aug 14, 2020

SELL
$2.34 - $3.53 $16,967 - $25,596
-7,251 Reduced 23.45%
23,664 $70,000
Q1 2020

May 14, 2020

SELL
$2.3 - $5.5 $4,669 - $11,165
-2,030 Reduced 6.16%
30,915 $84,000
Q4 2019

Feb 14, 2020

SELL
$3.0 - $5.0 $64,671 - $107,785
-21,557 Reduced 39.55%
32,945 $111,000
Q3 2019

Nov 14, 2019

SELL
$3.31 - $5.6 $110,117 - $186,300
-33,268 Reduced 37.9%
54,502 $207,000
Q2 2019

Aug 15, 2019

SELL
$5.28 - $8.2 $255,979 - $397,544
-48,481 Reduced 35.58%
87,770 $497,000
Q2 2019

Aug 14, 2019

BUY
$5.28 - $8.2 $719,405 - $1.12 Million
136,251 New
136,251 $996,000

Others Institutions Holding EQ

About Equillium, Inc.


  • Ticker EQ
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,352,100
  • Market Cap $25.8M
  • Description
  • Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. The company's lead product candidate is itolizumab (EQ001), a clinical-stage monoclonal antibody that targets the novel immune checkpoint receptor CD6, which i...
More about EQ
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.